APA (7th ed.) Citation

MS, B., NM, B., SB, B., G, D., GE, F., LA, H., . . . S, V. (2002). Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. Archives of ophthalmology (Chicago, Ill. : 1960), 120(10), 1307. https://doi.org/10.1001/archopht.120.10.1307

Chicago Style (17th ed.) Citation

MS, Blumenkranz, et al. "Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration: Three-year Results of an Open-label Extension of 2 Randomized Clinical Trials--TAP Report No. 5." Archives of Ophthalmology (Chicago, Ill. : 1960) 120, no. 10 (2002): 1307. https://doi.org/10.1001/archopht.120.10.1307.

MLA (9th ed.) Citation

MS, Blumenkranz, et al. "Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration: Three-year Results of an Open-label Extension of 2 Randomized Clinical Trials--TAP Report No. 5." Archives of Ophthalmology (Chicago, Ill. : 1960), vol. 120, no. 10, 2002, p. 1307, https://doi.org/10.1001/archopht.120.10.1307.